Recent REGN Stock Price | REGN Stock Predictions | |
$890.68 | +15.35% |
$1027.38 |
Recent REGN Analyst Ratings Breakdown, Making REGN Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 18 | 18 | 17 | 17 |
Buy ratings: | 1 | 1 | 1 | 1 |
Hold ratings: | 5 | 5 | 4 | 4 |
Sell ratings: | 1 | 1 | 1 | 1 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.56 | 1.56 | 1.52 | 1.52 |
For the REGN stock predictions from the analysts covering Regeneron Pharmaceuticals, Inc., we have collected all of the individual REGN stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 21 different analysts covering REGN (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since REGN stock predictions may vary widely, another useful metric to consider is the median REGN stock prediction, which represents the price at which half of the analysts
made REGN stock predictions that were higher and half made REGN stock predictions that were lower. This makes for a different take on the REGN stock predictions out there, as compared to average or mean.
And that median across all the individual REGN stock predictions was: $1041.0 as of 2024-04-26.
The very highest of the REGN stock predictions for one year price target was $1189.0, while the very lowest of the REGN stock predictions in the analyst group was
$720.0 (with a standard deviation of $111.298). Get the latest Zacks research report on REGN — FREE
Find out: REGN next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
MLHR Stock Predictions
RLI Stock Predictions
V Stock Predictions
BMI Stock Predictions
STWD Stock Predictions
MGTA Stock Predictions
CVCY Stock Predictions
UA Stock Predictions
MRTX Stock Predictions
|
|
Buy (3.44 out of 4) 57th percentile
(ranked higher than approx. 57% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |